AKTS peer analysis
Aktis Oncology (AKTS) against its competitors: price, today's move, 1-year return and market value side by side.
AKTS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| AKTX Akari Therapeutics | $8.00 | -13.04% | -73.35% | $18.83M |
| AURA Aura Biosciences | $6.03 | -1.79% | -1.63% | – |
| BCYC Bicycle Therapeutics | $3.62 | -1.09% | -55.14% | $256.54M |
| IMCR Immunocore | $29.79 | -2.30% | -9.97% | – |
| IMNM Immunome | $19.57 | -0.10% | 21.78% | – |
| MGNX MacroGenics | $2.33 | -2.92% | 40.36% | $152.88M |
| AKTS Aktis Oncology | $14.59 | -8.41% | – | $886.02M |
- AKTS's peers: AKTX (Akari Therapeutics), AURA (Aura Biosciences), BCYC (Bicycle Therapeutics), IMCR (Immunocore), IMNM (Immunome), MGNX (MacroGenics).
Updated 2026-11-03 12:36 UTC